Novel BRD4-Degrading Proteolysis Targeting Chimera (PROTACs) Exert Potent Single Agent and Synergistic Activity with Ibrutinib and Venetoclax Against Human Mantle Cell Lymphoma (MCL) Cells

Saved in:
Bibliographic Details
Published in:Clinical lymphoma, myeloma and leukemia myeloma and leukemia, 2016-09, Vol.16, p.S108-S109
Main Authors: Bhalla, Kapil, Sun, Baohua, Fiskus, Warren, Zhang, Liang, Saenz, Dyana, Mill, Christopher, Wang, Michael
Format: Article
Language:English
Subjects:
Hematology, Oncology and Palliative Medicine
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:2152-2650
2152-2669
DOI:10.1016/j.clml.2016.07.157